Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Guangzhou Medical University has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are handled by 2 distinct examiners in 2 distinct art units, indicating separate examination paths.
HASTINGS, ALISON AZAR is the busiest examiner, with 1 pending matter. Counsel should tailor each response to its own examiner and technical unit while maintaining consistent treatment of any related biotechnology claim language.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HASTINGS, ALISON AZAR | 1 | 62.5% | +42.1% |
| MALIK, VIPUL | 1 | 62.5% | +36.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18993576 | SYNTHESIS METHOD AND APPLICATION OF BENZOTHIASELENAZOLE-1-OXIDE COMPOUND AND DERIVATIVE THEREOF | HASTINGS, ALISON AZAR | — |
| 18921040 | VOLUMETRIC THREE-DIMENSIONAL BIOPRINTING DEVICE | MALIK, VIPUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18993576 | SYNTHESIS METHOD AND APPLICATION OF BENZOTHIASELENAZOLE-1-OXIDE COMPOUND AND DERIVATIVE THEREOF | HASTINGS, ALISON AZAR | — |
| 18921040 | VOLUMETRIC THREE-DIMENSIONAL BIOPRINTING DEVICE | MALIK, VIPUL | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| 1754 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18993576 | SYNTHESIS METHOD AND APPLICATION OF BENZOTHIASELENAZOLE-1-OXIDE COMPOUND AND DERIVATIVE THEREOF | HASTINGS, ALISON AZAR | 1627 | §101§112 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 18921040 | VOLUMETRIC THREE-DIMENSIONAL BIOPRINTING DEVICE | MALIK, VIPUL | 1754 | §102§103§112 | Non-Final OA | — | Pending | Oct 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGuangzhou Medical University has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Alison Azar Hastings has the most, with 1 of Guangzhou Medical University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
